Literature DB >> 9371817

Interaction between HLA-DM and HLA-DR involves regions that undergo conformational changes at lysosomal pH.

H J Ullrich1, K Döring, U Grüneberg, F Jähnig, J Trowsdale, S M van Ham.   

Abstract

Antigenic peptide loading of major histocompatibility complex class II molecules is enhanced by lysosomal pH and catalyzed by the HLA-DM molecule. The physical mechanism behind the catalytic activity of DM was investigated by using time-resolved fluorescence anisotropy (TRFA) and fluorescence binding studies with the dye 8-anilino-1-naphthalenesulfonic acid (ANS). We demonstrate that the conformations of both HLA-DM and HLA-DR3, irrespective of the composition of bound peptide, are pH sensitive. Both complexes reversibly expose more nonpolar regions upon protonation. Interaction of DM with DR shields these hydrophobic domains from the aqueous environment, leading to stabilization of the DM and DR conformations. At lysosomal pH, the uncovering of additional hydrophobic patches leads to a more extensive DM-DR association. We propose that DM catalyzes class II peptide loading by stabilizing the low-pH conformation of DR, favoring peptide exchange. The DM-DR association involves a larger hydrophobic surface area with DR/class II-associated invariant chain peptides (CLIP) than with stable DR/peptide complexes, explaining the preferred association of DM with the former. The data support a release mechanism of DM from the DM-DR complex through reduction of the interactive surface, upon binding of class II molecules with antigenic peptide or upon neutralization of the DM-DR complex at the cell surface.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371817      PMCID: PMC24280          DOI: 10.1073/pnas.94.24.13163

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Structures of an MHC class II molecule with covalently bound single peptides.

Authors:  D H Fremont; W A Hendrickson; P Marrack; J Kappler
Journal:  Science       Date:  1996-05-17       Impact factor: 47.728

2.  Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM.

Authors:  A B Vogt; H Kropshofer; G Moldenhauer; G J Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

Review 3.  Time-resolved fluorescence of proteins.

Authors:  J M Beechem; L Brand
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

4.  Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading.

Authors:  R J Riese; P R Wolf; D Brömme; L R Natkin; J A Villadangos; H L Ploegh; H A Chapman
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

5.  Effect of orientational order on the decay of the fluorescence anisotropy in membrane suspensions. A new approximate solution of the rotational diffusion equation.

Authors:  W van der Meer; H Pottel; W Herreman; M Ameloot; H Hendrickx; H Schröder
Journal:  Biophys J       Date:  1984-10       Impact factor: 4.033

6.  The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites.

Authors:  L Stryer
Journal:  J Mol Biol       Date:  1965-09       Impact factor: 5.469

7.  Editing of the HLA-DR-peptide repertoire by HLA-DM.

Authors:  H Kropshofer; A B Vogt; G Moldenhauer; J Hammer; J S Blum; G J Hämmerling
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

8.  Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface.

Authors:  R Wubbolts; M Fernandez-Borja; L Oomen; D Verwoerd; H Janssen; J Calafat; A Tulp; S Dusseljee; J Neefjes
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

9.  Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM.

Authors:  D A Weber; B D Evavold; P E Jensen
Journal:  Science       Date:  1996-10-25       Impact factor: 47.728

10.  Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs.

Authors:  S M van Ham; U Grüneberg; G Malcherek; I Bröker; A Melms; J Trowsdale
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

View more
  13 in total

1.  Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange.

Authors:  Corrie A Painter; Maria P Negroni; Katherine A Kellersberger; Zarixia Zavala-Ruiz; James E Evans; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

Review 2.  HLA-DM: arbiter conformationis.

Authors:  Andrea Ferrante
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

3.  A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules.

Authors:  Olaf Rötzschke; Julie M Lau; Maria Hofstätter; Kirsten Falk; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-05       Impact factor: 11.205

4.  HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes.

Authors:  Kedar Narayan; Chih-Ling Chou; AeRyon Kim; Isamu Z Hartman; Sarat Dalai; Stanislav Khoruzhenko; Scheherazade Sadegh-Nasseri
Journal:  Nat Immunol       Date:  2006-12-03       Impact factor: 25.606

5.  Conformational variants of class II MHC/peptide complexes induced by N- and C-terminal extensions of minimal peptide epitopes.

Authors:  O Rötzschke; K Falk; J Mack; J M Lau; G Jung; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

6.  HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.

Authors:  C L Chou; S Sadegh-Nasseri
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

7.  HLA-DM mediates peptide exchange by interacting transiently and repeatedly with HLA-DR1.

Authors:  Kedar Narayan; Katherine W Su; Chih-Ling Chou; Stanislav Khoruzhenko; Scheherazade Sadegh-Nasseri
Journal:  Mol Immunol       Date:  2009-07-31       Impact factor: 4.407

Review 8.  What to do with HLA-DO/H-2O two decades later?

Authors:  Robin Welsh; Nianbin Song; Scheherazade Sadegh-Nasseri
Journal:  Immunogenetics       Date:  2019-01-26       Impact factor: 2.846

9.  Evidence for a human leucocyte antigen-DM-induced structural change in human leucocyte antigen-DObeta.

Authors:  Francis Deshaies; Djibril A Diallo; Jean-Simon Fortin; Helen M O'Rourke; Abdul Mohammad Pezeshki; Angélique Bellemare-Pelletier; Nicola Raby; Nathalie Bédard; Alexandre Brunet; Lisa K Denzin; Jacques Thibodeau
Journal:  Immunology       Date:  2008-11-14       Impact factor: 7.397

10.  In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange.

Authors:  Melissa J Call; Xuechao Xing; Gregory D Cuny; Nilufer P Seth; Daniel M Altmann; Lars Fugger; Michelle Krogsgaard; Ross L Stein; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.